8-K: Healthcare Realty Trust Reports Mixed Q4 Results, Provides 2024 Guidance

Healthcare Realty Trust reported a net loss for the fourth quarter of 2023, but saw growth in same-store cash NOI and provided 2024 guidance.

Summary

• Healthcare Realty Trust reported a net loss of $(40.5) million, or $(0.11) per diluted share, for the fourth quarter of 2023.
• The company's normalized FFO was $150.7 million, or $0.39 per diluted share, for the same period.
• Merger Combined Same Store cash NOI increased by 2.7% in the fourth quarter and 2.8% for the full year 2023.
• The multi-tenant portfolio experienced a sequential occupancy improvement of 175,000 square feet, or 53 basis points, during the quarter.
• The company sold 27 properties for $338 million in the fourth quarter and an additional 36 properties for $656 million in 2023, with an average cap rate of 6.6%.
• Net debt to adjusted EBITDA was 6.4 times at the end of the quarter.
• Variable rate debt improved to 8% as of December 31, 2023, from 13% at the end of 2022.
• A dividend of $0.31 per share was paid in November 2023, and another dividend of $0.31 per share is scheduled for March 14, 2024.
• The company's 2024 guidance projects normalized FFO per share between $1.52 and $1.58.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative due to the reported net loss, but there are positive aspects such as same-store NOI growth and improved debt metrics. The 2024 guidance is cautiously optimistic.

Positives

• Merger Combined Same Store cash NOI showed growth of 2.7% for the quarter and 2.8% for the year.
• The multi-tenant portfolio experienced a sequential occupancy improvement of 175,000 square feet.
• Variable rate debt decreased to 8% from 13% year-over-year.
• The company successfully executed interest rate swaps totaling $275 million during the quarter.
• The company's line of credit balance was fully repaid as of December 31, 2023.
• The company is projecting positive growth in multi-tenant and single-tenant cash NOI for 2024.

Negatives

• The company reported a net loss of $(40.5) million for the fourth quarter of 2023.
• The company's net loss for the year ended December 31, 2023 was $(278.3) million.
• The company's earnings per share for the quarter was $(0.11) and $(0.74) for the year.
• The company's 2024 guidance does not include any assumptions for prospective acquisitions, joint venture seed portfolios or other related balance sheet activities that have not closed.

Risks

• The company's actual results may vary materially from the provided guidance.
• The company's guidance does not contemplate impacts from gains or losses from dispositions, potential impairments, or debt extinguishment costs.
• The company faces risks related to the integration of the merger with Healthcare Trust of America.
• The company is exposed to general adverse economic and local real estate conditions.
• Changes in interest rates and the availability of capital could impact the company's performance.
• The company is subject to competition in the real estate industry.
• Pandemics and other health concerns could have a material adverse effect on the company's business.

Future Outlook

The company's 2024 guidance projects normalized FFO per share between $1.52 and $1.58, with growth in multi-tenant and single-tenant cash NOI. The guidance does not include any assumptions for prospective acquisitions, joint venture seed portfolios or other related balance sheet activities that have not closed.

Industry Context

This announcement reflects the ongoing challenges and opportunities in the healthcare REIT sector, particularly in managing occupancy and growth post-merger. The focus on same-store NOI growth and strategic dispositions is consistent with industry trends.

Comparison to Industry Standards

• The reported net loss is worse than some peers in the REIT sector, which have shown positive earnings.
• The 2.7% increase in same-store NOI is in line with some industry benchmarks, but below the top performers.
• The company's debt to EBITDA ratio of 6.4x is within the acceptable range for REITs, but some peers have lower leverage.
• The average cap rate of 6.6% on dispositions is comparable to other REITs selling assets in the current market.
• The occupancy improvement of 53 basis points is a positive sign, but the company needs to continue to improve occupancy to meet industry standards.
• Companies such as Ventas (VTR) and Welltower (WELL) are comparable in size and scope, but have shown different results in terms of earnings and growth.

Stakeholder Impact

• Shareholders will be impacted by the net loss and the 2024 guidance.
• Employees may be affected by the company's strategic decisions and performance.
• Tenants will be impacted by the company's leasing and property management activities.
• Creditors will be impacted by the company's debt management and financial performance.

Next Steps

• The company will hold a conference call on February 16, 2024, to discuss earnings results and operations.
• The company will continue to focus on strategic dispositions and redevelopments to improve portfolio quality.
• The company will aim to improve occupancy and leasing activity in the coming quarters.

Key Dates

Keywords

Healthcare Realty Trust, REIT, Medical Outpatient Buildings, Real Estate, FFO, NOI, Occupancy, Dispositions, Debt, Dividends